AK-HW-90 (compound 2B) is a potent pan Bcr-Abl inhibitor with significant inhibitory activity against Imatinib ( HY-15463 )-resistant mutants. AK-HW-90 inhibits the resistance mutant Bcr-Abl T315I with an IC 50 of 0.65 nM. AK-HW-90 has potential anticancer activity and can be used in the study of chronic myelogenous leukemia (CML).
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Signaling Pathways > Bcr-Abl
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.